Clinical application of glucagon-like peptide-1 receptor agonists in cardiovascular disease: lessons from recent clinical cardiovascular outcomes trials

Recent clinical trials investigating cardiovascular (CV) safety of newer antidiabetic agents have been rapidly and largely changing the landscape of diabetes care and providing highly important clinical inform...

Source: Cardiovascular Diabetology - June 12, 2018 Category: Cardiology Authors: Atsushi Tanaka and Koichi Node Tags: Commentary Source Type: research